A new study has explored the potential of Dextromethorphan, an FDA-approved drug, in the treatment of lung fibrosis. Lung fibrosis occurs after accumulation of scar tissue in the lung (left image ...
Fibrotic scarring causes lung tissue stiffness, which leads to breathing difficulties and reduces oxygen concentration in the bloodstream, ultimately resulting in organ failure. Since 2019 ...